{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:41:32Z","timestamp":1767397292512,"version":"3.48.0"},"reference-count":39,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1055\/a-2763-7391","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:37:43Z","timestamp":1767397063000},"page":"107-111","source":"Crossref","is-referenced-by-count":0,"title":["Thrombosis and Haemostasis 2025 Editors' Choice"],"prefix":"10.1055","volume":"126","author":[{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rigby","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Department of Cardiology, Lipidology and Internal Medicine with Intensive Coronary Care Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/a-2508-5708","article-title":"A European-multicenter network for the implementation of artificial intelligence to manage complexity and comorbidities of atrial fibrillation patients: the ARISTOTELES consortium","volume":"125","author":"G Boriani","year":"2025","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/a-2460-2894","article-title":"The rise of the machines: using machine learning to assess thrombosis and bleeding risks, and optimizing anticoagulation strategies","volume":"125","author":"S Ortega-Martorell","year":"2025","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/a-2438-5671","article-title":"TARGET: a major European project aiming to advance the personalised management of atrial fibrillation-related stroke via the development of health virtual twins technology and artificial intelligence","volume":"125","author":"S Ortega-Martorell","year":"2025","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"124","author":"M Grymonprez","year":"2024","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u201cAtrial Fibrillation Better Care\u201d pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"G F Romiti","year":"2023","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"S Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-Asian cohorts","volume":"125","author":"H-C Chang","year":"2025","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"T Potpara","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/a-2690-1674","article-title":"Racial differences in bleeding risks among patients with atrial fibrillation: an ecological epidemiological study comparing Korea and UK population","author":"D S Kang","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-2615-4591","article-title":"Venous thromboembolism outcomes by geographic region and self-reported race: insights from the RIETE registry","author":"A J Tafur","year":"2025","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/a-2496-5492","article-title":"Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation: rationale and design for PRESTIGE-AF trial","volume":"125","author":"E Korompoki","year":"2025","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/a-2536-8739","article-title":"Identifying risk factors for left ventricular thrombus in patients with ischemic left ventricular aneurysm using cardiac MRI","volume":"125","author":"Y Wu","year":"2025","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/a-2576-8009","article-title":"Navigating anticoagulation in ischemic left ventricular aneurysms: lessons from cardiac magnetic resonance imaging","volume":"125","author":"A Hashemi","year":"2025","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1055\/a-2548-4192","article-title":"Antithrombotic therapy in people with hemophilia\u2014a narrative review","volume":"125","author":"A Nagao","year":"2025","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1055\/a-2521-0923","article-title":"Influence of direct oral anticoagulant levels and thrombin generation on postoperative bleeding [SONAR]: a nested case-control study","volume":"125","author":"J R Shaw","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1055\/a-2524-5334","article-title":"Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease","author":"E K Kempers","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1055\/a-2642-0241","article-title":"Performance of bleeding risk scores for major bleeding in anticoagulated patients with pulmonary embolism: insights from the CURES Registry-2","author":"Y Tao","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1055\/a-2653-6161","article-title":"Venous thromboembolism outcomes among cancer and non-cancer patients managed with patient-centric guideline-driven protocol","author":"C E Cassianni","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/a-2650-7959","article-title":"How to manage venous thromboembolism risk during pregnancy in patients with inherited antithrombin deficiency?","author":"L Mauge","year":"2025","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1055\/a-2510-6370","article-title":"Heterogeneity in American and European peripheral artery disease guidelines on non-statin lipid-lowering therapy and rivaroxaban","volume":"125","author":"M Zarghami","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1055\/a-2649-9451","article-title":"Critical review of international clinical practice guidelines recommendations for prevention, diagnosis, and management of central venous catheter thrombosis","author":"M Rosson","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/a-2665-2400","article-title":"Venous thrombosis associated with different types of SARS-CoV-2 vaccines in the Netherlands\u2014results of the TERA case-control study","author":"W J van Dijk","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/a-2645-3594","article-title":"Derivation and validation of a COPD-specific pulmonary embolism diagnostic strategy","author":"V Mai","year":"2025","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/a-2530-7553","article-title":"Utility of sepsis-induced coagulopathy among disseminated intravascular coagulation diagnostic criteria: a multicenter retrospective validation study","volume":"125","author":"S Gando","year":"2025","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1055\/a-2523-1821","article-title":"Recent advances in immunothrombosis and thromboinflammation","volume":"125","author":"R Kaiser","year":"2025","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/a-2493-2499","article-title":"Neutrophil extracellular traps, platelets and endothelial cells cooperatively contribute to hypercoagulability in non-small cell lung cancer","volume":"125","author":"D Tong","year":"2025","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1055\/a-2504-1559","article-title":"Factor XIII-A transglutaminase contributes to neutrophil extracellular trap (NET)-mediated fibrin(ogen) network formation and crosslinking","volume":"125","author":"F Soltani","year":"2025","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1055\/a-2498-4849","article-title":"Endothelial damage in JAK2V617F myeloproliferative neoplasms with splanchnic vein thrombosis","volume":"125","author":"B De Moner","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1055\/a-2615-4682","article-title":"Association of fibrinogen variants with severity of obesity and metabolic liver disease: 2-year follow-up after bariatric surgery","author":"N B Pedersen","year":"2025","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/a-2562-4516","article-title":"Platelets from COVID-19 patients show an altered nitric oxide\/reactive oxygen species production balance","volume":"125","author":"E Petito","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/a-2561-8818","article-title":"Platelet disorders and medication strategies","author":"Z Zhang","year":"2025","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1055\/a-2525-4219","article-title":"Changes in coagulation factor XI activity levels in patients with ST-segment elevation myocardial infarction undergoing primary PCI","volume":"125","author":"M Spagnolo","year":"2025","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/a-2593-1763","article-title":"Factor XI inhibitors for myocardial infarction: a safer path to thrombotic protection?","volume":"125","author":"M Spagnolo","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1055\/a-2703-4109","article-title":"Elevated factor XI is associated with first and recurrent left atrial appendage thrombus of unknown origin","author":"A Bana\u015b","year":"2025","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1055\/a-2674-5114","article-title":"Lipoprotein(a) and venous thromboembolism: association, causality, and medications","volume":"125","author":"M B Pfeferman","year":"2025","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2763-7391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:39:06Z","timestamp":1767397146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2763-7391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2763-7391","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}